Silk Competitors

Delisted . USA . 
Stock . Silk Road Medical
SILKDelisted Stock  USD 27.49  0.00  0.00%   
Silk Road Medical competes with LivaNova PLC, Orthopediatrics Corp, Pulmonx Corp, Si Bone, and Neuropace; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Silk Road competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Silk Road to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Silk Road competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
27.2527.4927.73
Details
Intrinsic
Valuation
LowRealHigh
23.0223.2630.24
Details

Silk Road Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Silk Road and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Silk and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Silk Road Medical does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
SGHT
+ 0.93
TMDX
RXST
+ 0.88
KIDS
OFIX
+ 0.88
NARI
SGHT
+ 0.78
RXST
OFIX
+ 0.77
NPCE
SIBN
+ 0.75
KIDS
  
High negative correlations   
TMDX
- 0.84
NARI
SGHT
- 0.77
NARI
KIDS
- 0.72
LIVN
SGHT
- 0.7
OFIX
OFIX
- 0.68
TMDX
SGHT
- 0.61
NPCE

Risk-Adjusted Indicators

There is a big difference between Silk Stock performing well and Silk Road Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Silk Road's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
LIVN  1.22  0.01  0.00  0.13  1.49 
(1.16)
 3.53 
(2.55)
 8.68 
KIDS  2.50 (0.41) 0.00 (0.21) 0.00 
 0.00 
 4.85 
(5.08)
 16.62 
LUNG  3.18 (0.38) 0.00 (0.07) 0.00 
 0.00 
 8.44 
(6.89)
 20.44 
SIBN  2.83 (0.42) 0.00 (0.11) 0.00 
 0.00 
 5.99 
(4.54)
 26.24 
NPCE  3.44  0.30  0.13  0.26  3.01 
(4.11)
 9.73 
(6.19)
 35.38 
NARI  2.23  0.26  0.08  0.90  2.06 
(2.76)
 6.30 
(3.84)
 19.78 
TMDX  3.15 (1.11) 0.00 (0.46) 0.00 
 0.00 
 5.99 
(7.44)
 39.98 
OFIX  1.86  0.03  0.04  0.15  2.06 
(2.07)
 3.90 
(3.85)
 12.11 
RXST  1.68 (0.36) 0.00 (0.18) 0.00 
 0.00 
 2.19 
(5.18)
 12.89 
SGHT  3.00 (1.14) 0.00 (0.22) 0.00 
 0.00 
 6.65 
(7.84)
 18.22 
All Fundamental Data

Silk Road Competitive Analysis

The better you understand Silk Road competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Silk Road's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Silk Road's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SILK LIVN KIDS LUNG SIBN NPCE NARI TMDX OFIX RXST
 0.00 
 27.49 
Silk
 0.04 
 52.50 
LivaNova
 2.32 
 25.98 
Orthopediatrics
 2.38 
 6.45 
Pulmonx
 2.19 
 13.56 
SIBN
 3.41 
 10.60 
Neuropace
 1.74 
 51.92 
Inari
 0.46 
 86.71 
TransMedics
 2.09 
 19.53 
Orthofix
 1.03 
 46.88 
Rxsight
Market Volatility
(90 Days Market Risk)
Very steady
Very steady
Very steady
Slightly risky
Not too volatile
Moderately volatile
Very steady
Very steady
Not too volatile
Very steady
Market Performance
(90 Days Performance)
Solid
Insignificant
Very Weak
Weak
Very Weak
OK
OK
Very Weak
OK
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Dangerous
Very Small
Low
Above Average
Low
Quite High
Low
Below Average
Low
Below Average
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Fairly Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Strong Buy
Buy
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Hold
Strong Sell
Sell
Cautious Hold
Cautious Hold
Hold
Cautious Hold
Cautious Hold
Hold
Current Ratio
6.92
2.92
4.75
9.43
8.9
9.86
10.04
12.11
3.15
11.54
Net Asset
265.31 M
2.43 B
438.75 M
177.78 M
230.43 M
107.65 M
674.24 M
706.05 M
925.32 M
182.55 M
Profit Margin
-0.3
0.0191
-0.15
-0.72
-0.24
-0.37
-0.14
0.0814
-0.15
-0.24
EBITDA
(55.48 M)
39.02 M
(8.38 M)
(55.09 M)
(34.45 M)
(22.83 M)
15.19 M
(7.6 M)
(79.45 M)
(41.04 M)
Operating Margin
-0.34
0.14
-0.1
-0.69
-0.19
-0.2
-0.0434
0.0361
-0.0861
-0.26
Current Valuation
1.02 B
3.18 B
625.74 M
202.73 M
456.4 M
333.06 M
2.96 B
3.1 B
853.5 M
1.66 B
Price To Book
7.22
2.18
1.7
2.71
3.45
32.21
6.99
13.86
1.42
6.81
Retained Earnings
(399.45 M)
(966.48 M)
(197.74 M)
(411.16 M)
(400.44 M)
(503.81 M)
(48.49 M)
(503.7 M)
(150.14 M)
(594.64 M)
Current Asset
N/A
240.72 M
44 M
N/A
266 K
N/A
N/A
N/A
147.87 M
N/A
Beta
1.54
1.01
1.16
0.68
1.23
1.8
0.96
2.07
1.05
1.19
Number Of Employees
474
2.9 K
247
279
344
184
1.3 K
584
1.63 K
374
Shares Outstanding
40.63 M
54.3 M
24.22 M
39.49 M
41.94 M
29.85 M
58.54 M
33.56 M
38.21 M
40.3 M
Cash Flow From Operations
(32.01 M)
74.91 M
(27.05 M)
(37.61 M)
(18.71 M)
(19.7 M)
35.93 M
(13.03 M)
(45.75 M)
(41.59 M)
Total Debt
84.63 M
640.4 M
10.06 M
41.42 M
38.99 M
72.39 M
32.05 M
515.95 M
134.2 M
3.01 M
Return On Equity
-0.36
0.0187
-0.0763
-0.52
-0.22
-2.15
-0.18
0.19
-0.21
-0.14
Return On Asset
-0.14
0.0434
-0.0394
-0.2
-0.12
-0.15
-0.0321
0.0284
-0.0237
-0.0992
Number Of Shares Shorted
3.15 M
2.36 M
801.13 K
842.69 K
1.27 M
290.4 K
3.42 M
8.98 M
1.66 M
3.03 M
Book Value Per Share
3.81
24.13
15.32
2.38
3.95
0.33
7.44
6.26
13.76
6.89
Current Liabilities
N/A
31.45 M
8.51 M
N/A
1.22 M
N/A
N/A
N/A
52.94 M
N/A
Total Asset
265.31 M
2.43 B
438.75 M
177.78 M
230.43 M
107.65 M
674.24 M
706.05 M
925.32 M
182.55 M
Debt To Equity
1.37
0.4
0.14
0.15
0.36
1.08
0.069
0.36
0.078
0.41
Short Ratio
2.48
4.69
4.8
3.68
2.75
2.7
3.75
4.25
5.43
5.07
Target Price
20.75
69.0
40.67
13.5
23.22
15.33
63.31
123.88
24.4
63.0
Shares Owned By Institutions
97.46
99.7
70.85
94.9
98.7
82.89
95.5
96.83
92.32
89.52
Market Capitalization
1.12 B
2.85 B
629.13 M
254.7 M
568.68 M
316.39 M
3.04 B
2.92 B
746.32 M
1.89 B
Price To Earnings To Growth
-0.26
0.5
N/A
-0.42
-1.04
N/A
-1.88
N/A
0.33
0.03
Price To Earning
N/A
78.67
-10.06
N/A
N/A
N/A
275.35
N/A
338.0
42.55
Price To Sales
5.83
2.3
3.32
3.21
3.62
4.14
5.29
7.29
0.95
14.73
Net Income
(55.74 M)
17.55 M
(20.97 M)
(60.84 M)
(43.34 M)
(32.96 M)
(1.64 M)
(25.03 M)
(151.4 M)
(48.61 M)
Earnings Per Share
-1.45
0.43
-1.23
-1.47
-0.91
-0.98
-1.35
0.93
-3.14
-0.81
Shares Owned By Insiders
4.15
0.3
32.52
5.0
2.32
4.1
8.65
3.17
4.99
5.0
Revenue
177.13 M
1.15 B
148.73 M
68.67 M
138.89 M
65.42 M
493.63 M
241.62 M
746.64 M
89.08 M
Working Capital
210.55 M
653.17 M
184.83 M
127.27 M
187.94 M
76.49 M
159.22 M
455.72 M
255.22 M
147.5 M
Cash And Equivalents
108.87 M
109.02 M
51.16 M
162.09 M
114.41 M
92.41 M
330.5 M
204.46 M
59.54 M
128.62 M
Cash Per Share
3.09
2.04
2.52
4.35
3.34
3.72
6.19
6.41
2.98
4.65
Gross Profit
100.76 M
696.73 M
90.66 M
39.87 M
90.7 M
32.49 M
338.96 M
65.27 M
337.17 M
21.33 M
Day Typical Price
27.49
52.65
25.86
6.41
13.55
10.58
51.6
87.53
19.4
46.9
Accumulation Distribution
N/A
0.0234
0.0384
0.0293
0.0348
0.028
0.0187
0.0321
0.0195
0.0409
Market Facilitation Index
N/A
1.25
1.01
0.19
0.48
0.3
0.97
2.87
0.38
1.96
Daily Balance Of Power
0.0
0.016
0.5842
0.7895
0.6042
1.166667
0.9175
(0.14)
1.052632
0.2449
Period Momentum Indicator
N/A
0.02
0.59
0.15
0.29
0.35
0.89
(0.40)
0.4
0.48
Rate Of Daily Change
1.0
1.0
1.02
1.02
1.02
1.03
1.02
1.0
1.02
1.01
Day Median Price
27.49
52.73
25.81
6.39
13.55
10.57
51.44
87.95
19.34
46.91
Price Action Indicator
N/A
(0.21)
0.47
0.14
0.16
0.2
0.93
(1.44)
0.39
0.21
Coefficient Of Variation
690.1
1253.82
(1,318)
(3,444)
(2,160)
867.7
1047.87
(595.46)
1101.92
(1,144)
Mean Deviation
0.159
1.22
2.5
3.18
2.83
3.44
2.23
3.15
1.86
1.68
Jensen Alpha
0.0296
0.0055
(0.41)
(0.38)
(0.42)
0.3049
0.2578
(1.11)
0.0348
(0.36)
Total Risk Alpha
(0.02)
(0.16)
(0.80)
(0.87)
(0.84)
(0.28)
(0.24)
(1.73)
(0.19)
(0.59)
Sortino Ratio
(0.42)
0.0015
N/A
N/A
N/A
0.1343
0.0788
N/A
0.036
N/A
Downside Variance
0.0604
3.33
N/A
N/A
N/A
12.49
4.81
N/A
4.75
N/A
Standard Deviation
0.2287
1.76
3.23
4.37
3.88
5.31
3.25
5.12
2.38
2.29
Kurtosis
2.16
1.13
0.919
1.22
3.81
10.24
6.93
15.27
0.543
1.4
Potential Upside
0.4067
3.53
4.85
8.44
5.99
9.73
6.3
5.99
3.9
2.19
Treynor Ratio
(0.46)
0.1332
(0.21)
(0.07)
(0.11)
0.2585
0.8987
(0.46)
0.1536
(0.18)
Maximum Drawdown
1.14
8.68
16.62
20.44
26.24
35.38
19.78
39.98
12.11
12.89
Variance
0.0523
3.1
10.46
19.05
15.09
28.22
10.58
26.24
5.67
5.24
Market Risk Adjusted Performance
(0.45)
0.1432
(0.20)
(0.06)
(0.1)
0.2685
0.9087
(0.45)
0.1636
(0.17)
Risk Adjusted Performance
0.0873
0.0666
(0.05)
(0.01)
(0.03)
0.0967
0.0806
(0.12)
0.0762
(0.06)
Skewness
0.2599
0.2451
(0.54)
0.3052
(0.76)
2.39
2.0
(2.68)
0.2472
(0.72)
Semi Deviation
0.0347
1.49
N/A
N/A
N/A
3.01
2.06
N/A
2.06
N/A
Information Ratio
(0.46)
0.0016
(0.12)
(0.06)
(0.08)
0.0893
0.0531
(0.19)
0.0329
(0.15)
Value At Risk
(0.33)
(2.55)
(5.08)
(6.89)
(4.54)
(6.19)
(3.84)
(7.44)
(3.85)
(5.18)
Expected Short fall
(0.21)
(1.16)
N/A
N/A
N/A
(4.11)
(2.76)
N/A
(2.07)
N/A
Downside Deviation
0.2459
1.82
N/A
N/A
N/A
3.53
2.19
N/A
2.18
N/A
Semi Variance
0.0012
2.23
N/A
N/A
N/A
9.08
4.23
N/A
4.24
N/A

Silk Road Competition Performance Charts

Five steps to successful analysis of Silk Road Competition

Silk Road's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Silk Road Medical in relation to its competition. Silk Road's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Silk Road in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Silk Road's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Silk Road Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Silk Road position

In addition to having Silk Road in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Electronic Equipment Thematic Idea Now

Electronic Equipment
Electronic Equipment Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Electronic Equipment theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Electronic Equipment Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Silk Stock

If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY